US Stock MarketDetailed Quotes
BPMC Blueprint Medicines
- 94.150
- -2.470-2.56%
Close Nov 22 16:00 ET
- 94.150
- 0.0000.00%
Post 16:20 ET
5.98BMarket Cap-45047P/E (TTM)
98.340High94.110Low663.58KVolume96.780Open96.620Pre Close63.46MTurnover1.06%Turnover RatioLossP/E (Static)63.53MShares121.90052wk High19.10P/B5.92BFloat Cap67.00052wk Low--Dividend TTM62.83MShs Float125.610Historical High--Div YieldTTM4.38%Amplitude13.040Historical Low95.629Avg Price1Lot Size
About Blueprint Medicines Company
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Company Profile
SymbolBPMC
Company NameBlueprint Medicines
Listing DateApr 30, 2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees655
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580
Company Executives
- Name
- Position
- Salary
- Kathryn Haviland
- Director, President and Chief Executive Officer
- 6.43M
- Dr. Philina Lee, PhD
- Chief Commercial Officer
- --
- Dr. Christopher K. Murray, PhD
- Chief Technical Operations and Quality Officer
- --
- Debra Durso-Bumpus
- Chief People Officer
- --
- Christina Rossi, M.B.A.
- Chief Operating Officer
- 2.81M
- Michael Landsittel, M.B.A.
- Chief Financial Officer
- 2.19M
- Tracey L. McCain, Esq.
- Chief Legal and Compliance Officer
- --
- Dr. Percy H. Carter, M.B.A.,PhD
- Chief Scientific Officer
- 2.30M
- Dr. Becker Hewes, M.D.
- Chief Medical Officer
- --
- Ariel Hurley
- Senior Vice President, Finance and Principal Accounting Officer
- --
- Dr. Fouad Namouni, M.D.
- President, Research and Development
- 2.80M
- Jeffrey W. Albers, J.D.
- Chairman of the Board
- 526.08K
- Alexis A. Borisy, A.M.
- Director
- 397.33K
- Daniella Beckman
- Independent Director
- 422.33K
- Dr. Nicholas Lydon, F.R.S.,PhD
- Independent Director
- 417.33K
- Dr. John Tsai, M.D.
- Independent Director
- 769.80K
- Lonnel Coats
- Independent Director
- 419.33K
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 419.33K
- Dr. Lynn Seely,M.D.
- Lead Independent Director
- 452.33K
- Habib Joseph Dable
- Independent Director
- 412.33K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
